Bone mineral density as a prognostic marker in patients with non-small cell lung cancer undergoing neoadjuvant chemoimmunotherapy.

World J Surg Oncol · 2026 · PMC12879409 · PMID 41508009

Europe PMC DOI

hedged sentences

0.0310

closest p · 0.6× alpha

0.0820

boldest claim

The sentences

near-significantp = 0.031actually significant

Patients ≥ 65 years and squamous cell carcinoma showed a lower MPR probability (uni: OR = 0.29, p = 0.010; multi: OR = 0.30, p = 0.020) and a near-significant association, respectively (uni: OR = 2.98, p = 0.031; multi: OR = 2.77, p = 0.067).

also in 2,306 other papers

did not reach statistical significancep = 0.082so close (0.05 < p ≤ 0.1)

Although patients with higher dL1 BMD also had relatively longer DFS, this did not reach statistical significance ( p = 0.082) (Figs. 3 A-C).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.